Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H J Groen

Showing results (41-50 of 76) with videos related to

Pageof 8
Sort By:
Caries Research|January 1, 1992
Clinically undetected occlusal dentine caries: a radiographic comparisonK L Weerheijm, H J Groen, A J Bast, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 10, 1999
Paclitaxel and carboplatin in the treatment of small-cell lung cancer patients resistant to cyclophosphamide, doxorubicin, and etoposide: a non-cross-resistant scheduleH J Groen, E Fokkema, B Biesma, et al.
Journal of Clinical Pharmacology|July 17, 2001
P-glycoprotein at the blood-brain barrier and analysis of drug transport with positron-emission tomographyN H Hendrikse, J Bart, E G de Vries, et al.
British Journal of Cancer|December 1, 1995
Carboplatin- and cisplatin-induced potentiation of moderate-dose radiation cytotoxicity in human lung cancer cell linesH J Groen, S Sleijfer, C Meijer, et al.
American Journal of Respiratory and Critical Care Medicine|December 1, 1995
Pulmonary function changes in lung-cancer patients treated with radiation with or without carboplatinH J Groen, T W van der Mark, A H van der Leest, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 4, 2001
Dose-finding and pharmacological study of ifosfamide in combination with paclitaxel and carboplatin in resistant small-cell lung cancerJ W van Putten, T Kerbush, E F Smit, et al.
British Journal of Cancer|October 1, 1995
Continuous carboplatin infusion during 6 weeks' radiotherapy in locally inoperable non-small-cell lung cancer: a phase I and pharmacokinetic studyH J Groen, A H van der Leest, E G de Vries, et al.
British Journal of Cancer|March 25, 2000
Activity of high-dose epirubicin combined with gemcitabine in advanced non-small-cell lung cancer: a multicenter phase I and II studyJ W van Putten, P Eppinga, Z Erjavec, et al.
British Journal of Cancer|March 25, 2000
A prolonged methoxymorpholino doxorubicin (PNU-152243 or MMRDX) infusion schedule in patients with solid tumours: a phase 1 and pharmacokinetic studyE Fokkema, J Verweij, A T van Oosterom, et al.
Blood|September 1, 1994
Effects of recombinant human interleukin-6 in cancer patients: a phase I-II studyM M van Gameren, P H Willemse, N H Mulder, et al.
Pageof 8

Showing results (41-50 of 76) with videos related to

Sort By:
Pageof 8
Caries Research|January 1, 1992
Clinically undetected occlusal dentine caries: a radiographic comparisonK L Weerheijm, H J Groen, A J Bast, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 10, 1999
Paclitaxel and carboplatin in the treatment of small-cell lung cancer patients resistant to cyclophosphamide, doxorubicin, and etoposide: a non-cross-resistant scheduleH J Groen, E Fokkema, B Biesma, et al.
Journal of Clinical Pharmacology|July 17, 2001
P-glycoprotein at the blood-brain barrier and analysis of drug transport with positron-emission tomographyN H Hendrikse, J Bart, E G de Vries, et al.
British Journal of Cancer|December 1, 1995
Carboplatin- and cisplatin-induced potentiation of moderate-dose radiation cytotoxicity in human lung cancer cell linesH J Groen, S Sleijfer, C Meijer, et al.
American Journal of Respiratory and Critical Care Medicine|December 1, 1995
Pulmonary function changes in lung-cancer patients treated with radiation with or without carboplatinH J Groen, T W van der Mark, A H van der Leest, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 4, 2001
Dose-finding and pharmacological study of ifosfamide in combination with paclitaxel and carboplatin in resistant small-cell lung cancerJ W van Putten, T Kerbush, E F Smit, et al.
British Journal of Cancer|October 1, 1995
Continuous carboplatin infusion during 6 weeks' radiotherapy in locally inoperable non-small-cell lung cancer: a phase I and pharmacokinetic studyH J Groen, A H van der Leest, E G de Vries, et al.
British Journal of Cancer|March 25, 2000
Activity of high-dose epirubicin combined with gemcitabine in advanced non-small-cell lung cancer: a multicenter phase I and II studyJ W van Putten, P Eppinga, Z Erjavec, et al.
British Journal of Cancer|March 25, 2000
A prolonged methoxymorpholino doxorubicin (PNU-152243 or MMRDX) infusion schedule in patients with solid tumours: a phase 1 and pharmacokinetic studyE Fokkema, J Verweij, A T van Oosterom, et al.
Blood|September 1, 1994
Effects of recombinant human interleukin-6 in cancer patients: a phase I-II studyM M van Gameren, P H Willemse, N H Mulder, et al.
Pageof 8